Efficacy and safety of peptide receptor radionuclide therapy in advanced radioiodine-refractory differentiated thyroid cancer and metastatic medullary thyroid cancer: a systematic review

Overview of attention for article published in BMC Cancer, May 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (75th percentile)
High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

news: 1 news outlet

Citations

dimensions_citation: 32 Dimensions

Readers on

mendeley: 33 Mendeley

Summary News Dimensions citations

So far, Altmetric has seen 2 news stories from 1 outlets.

Medullary Thyroid Cancer Management: 5 Things to Know

Medscape, 19 Jan 2023

Medullary thyroid cancer (MTC) is a rare a neuroendocrine tumor that arises from the parafollicular C cells of the thyroid…

Medullary Thyroid Cancer Management: 5 Things to Know

Medscape, 12 Jan 2023

Medullary thyroid cancer (MTC) is a rare a neuroendocrine tumor that arises from the parafollicular C cells of the thyroid…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.